Prokaryotic expression and renaturation of engineering chimeric Fab antibody against human hepatoma

doi:10.3748/wjg.v10.i14.2029

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 14

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3186)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-9) series.

Item

Count

PDF

345

HTML

2533

Figures (1-9)

308

Sum=3186

Jul 15, 2004 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Jul 15, 2004; 10(14): 2029-2033
Published online Jul 15, 2004. doi: 10.3748/wjg.v10.i14.2029

Full Size Figure Download Figure

Figure 3 Location analysis of cFd and cL expression products on SDS-PAGE. 1: High molecular mass marker; 2: Supernatant of induced pET32a/cFd; 3: Inclusion body of induced pET32a/cFd; 4: Supernatant of induced pET32a/cL; 5: Inclusion body of induced pET32a/cL.

Citation: Xing JL, Yang XM, Yao XY, Song F, Chen ZN. Prokaryotic expression and renaturation of engineering chimeric Fab antibody against human hepatoma. World J Gastroenterol 2004; 10(14): 2029-2033
URL: https://www.wjgnet.com/1007-9327/full/v10/i14/2029.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i14.2029